Evaluation of the Efficacy and Safety of Duodenal Mucosal Resurfacing Using the Revita ™ System in Subjects With Type 2 Diabetes on Insulin Therapy

Conditions:   Type 2 Diabetes;   NASH - Nonalcoholic Steatohepatitis;   NAFLD Interventions:   Device: Duodenal Mucosal Resurfacing (DMR) Procedure;   Device: Sham Sponsor:   Fractyl Laboratories, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials